Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study

Neurology. 2003 Jul 8;61(1):141-2. doi: 10.1212/01.wnl.0000070186.97463.a7.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / metabolism
  • Brain / metabolism
  • Choline / metabolism
  • Creatine / adverse effects
  • Creatine / metabolism
  • Creatine / therapeutic use*
  • Diarrhea / chemically induced
  • Dietary Supplements
  • Dose-Response Relationship, Drug
  • Humans
  • Huntington Disease / diagnosis
  • Huntington Disease / drug therapy*
  • Huntington Disease / metabolism
  • Magnetic Resonance Spectroscopy
  • Muscle, Skeletal / metabolism
  • Nausea / chemically induced
  • Neuropsychological Tests
  • Phosphocreatine / metabolism
  • Pilot Projects
  • Reference Values
  • Safety
  • Treatment Outcome

Substances

  • Phosphocreatine
  • Aspartic Acid
  • Adenosine Triphosphate
  • N-acetylaspartate
  • Creatine
  • Choline